Research from UC Santa Cruz indicates that the P3 peptide—an alternative cleavage product of the amyloid precursor protein—may play a role in Alzheimer’s disease.

Add Yahoo as a preferred source to see more of our stories on Google. Panoramic dental X-Ray with finger pointing at right side In recent years, an increasing number of scientific investigations have ...

Alzheimer's disease (AD) is a neurodegenerative disease that causes progressive memory loss and a significant decline in mental functions. Past studies have shown that people with AD exhibit a buildup ...

Anavex Life Sciences Corp. AVXL on Friday announced that a new peer-reviewed study published by the University of California in Proceedings of the National Academy of Sciences, Nexus supports the ...

Alzheimer's disease is the most common cause of dementia, and it affects over 7 million people in the United States alone.

NHS watchdog to review evidence on two pioneering Alzheimer’s drugs - Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their ben ...

Alzheimer’s Disease scares people, and it should. It is one thing to lose your life – it’s another to lose your mind. Alzheimer’s rates rise with age, and people are living longer. Recent studies show ...

Researchers from Drexel University’s College of Arts and Sciences and College of Medicine have found a potential new therapeutic target for Alzheimer’s disease. Expanding on their previous research on ...

Jens Pahnke and his team at the University of Oslo has recently published results in the prestigious scientific journal 'BRAIN' showing that decreased removal of toxic peptides in the brain causes the ...

Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

In recent years, an increasing number of scientific investigations have backed an alarming hypothesis: Alzheimer's disease may not be merely a condition of an aging brain, but the product of infection ...